A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
スポンサーリンク
概要
- 論文の詳細を見る
- 2009-06-15
著者
-
MORI Shinichiro
Hematopoietic Stem Cell Transplantation Unit, National Cancer Center Hospital
-
三木 義男
癌研ゲノムセンター
-
Morishima Y
Department Of Hematology Kinki University School Of Medicine
-
Moriwaki Yuji
長崎大学大学院医歯薬学総合研究科附属原爆後障害医療研究施設 分子治療研究分野
-
Kishimoto Yuji
The First Department Of Internal Medicine Kansai Medical University
-
岡田 昌也
兵庫医科大学総合内科学血液・腫瘍科
-
Tsuboi Naoya
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
JINNAI Itsuro
Nagasaki CML Study Group
-
Tomonari Akira
東京大学医科学研究所附属病院 血液腫瘍内科
-
Tomonari Akira
Department Of Hematology/oncology The Institute Of Medical Science The University Of Tokyo
-
Tomonari Akira
Department Of Hematology/oncology
-
MEGURO KUNIAKI
National Sendai Hospital
-
Kagami Y
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
Naoe Tomoki
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Tsuboi Naoya
Cardiovascular Center Nagoya Daini Red Cross Hospital
-
Tsuboi Naoya
Division Of Cardiology Nagoya Daini Red Cross Hospital
-
Minauchi Koichiro
Second Department Of Medicine Hokkaido University Graduate School Of Medicine
-
Kobayashi Y
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
Usubuchi Noriko
国立がんセンター中央病院
-
Usubuchi Noriko
Hematology And Oncology Division National Cancer Center Hospital East
-
Uike Naokuni
Department Of Hematology National Kyushu Cancer Center
-
Uike Naokuni
Department Of Hematology National Kyushu Cancer Center Hospital
-
Uike N
National Kyusyu Cancer Center
-
USUI Noriko
Jikei University School of Medicine
-
NAOE Tomoki
Nagoya University
-
MIYAZAKI Yasushi
Nagasaki University
-
OKAMOTO Shinichiro
Keio University
-
Kagami Yoshitoyo
東海大学 医学部血液･腫瘍内科
-
Kagami Yoshitoyo
名古屋大学医学部附属病院 病理部
-
Kagami Yoshitoyo
東京大学医科学研究所ヒトゲノム解析センター
-
Jinnai Itsuro
長崎大学医学部歯学部附属病院 輸血部
-
Okada Masaya
Division Of Hematology And Oncology Department Of Internal Medicine Hyogo College Of Medicine
-
Okada Masaya
兵庫医科大学 総合内科
-
Okada Masaya
Division Of Hematology Department Of Internal Medicine Hyogo College Of Medicine
-
Uoshima Nobuhiko
京都府立医科大学 血液･腫瘍内科学
-
Uoshima Nobuhiko
Matsushita Memorial Hospital Moriguchi Jpn
-
Uoshima Nobuhiko
1st Department Of Internal Medicine Kyoto Prefectureal University Of Medicine
-
Okamoto S
Division Of Hematology Department Of Medicine Keio University School Of Medicine
-
Okamoto Shinichiro
慶応義塾大学 医学部内科学血液研究室
-
Naoe Tomoki
名古屋大学 医学系研究科血液･腫瘍内科学
-
Naoe Tomoki
大垣市民病院 血液内科
-
Usui Noriko
東京慈恵会医科大学附属病院 中央検査部
-
Usui N
Division Of Hematology And Oncology Department Of Medicine Jikei University
-
Okamoto Shin-ichiro
国立がんセンター中央病院 血液内科
-
Ohnishi K
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Ohnishi Kazunori
東北大学病院 血液･免疫科
-
Jinnai Itsuro
International Medical Center Saitama Medical University
-
OKADA Masaya
The Hospital of Hyogo College of Medicine
-
TOJO Arinobu
The Institute of Medical Science, The University of Tokyo
-
USUKI Kensuke
NTT Kanto Medical Center
-
URABE Akio
NTT Kanto Medical Center
-
MAEDA Yasuhiro
Kinki University School of Medicine
-
KOBAYASHI Yukio
National Cancer Center Hospital
-
OHYASHIKI Kazuma
Tokyo Medical University Hospital
-
NISHIMURA Miki
Chiba University Hospital
-
KAWAGUCHI Tatsuya
Kumamoto University Hospital
-
TANAKA Hideo
Hiroshima University Hospital
-
MIYAMURA Koichi
Japanese Red Cross Nagoya First Hospital
-
HUGHES Timothy
Hanson Institute Centre for Cancer
-
BRANFORD Susan
Hanson Institute Centre for Cancer
-
ISHIKAWA Jun
Osaka University Hospital
-
TANII Hiromi
Novartis Pharma Japan
-
AMAGASAKI Taro
Novartis Pharma Japan
-
NATORI Hiroko
Novartis Pharma Japan
-
TAGUCHI Hirokuni
Kochi Medical School
-
Yamamoto Kazuhito
愛知県がんセンター中央病院 血液･細胞療法部
-
Kanakura Yuzuru
大阪大学 医学系研究科心臓血管外科
-
Taguchi Hirokuni
浜松医科大学 内科学第3
-
Usui N
Jikei University Hospital
-
Matsumoto-mishima Yuko
癌研究会癌化学療法センター 臨床研究部
-
Nishimura Miki
Chiba Univ. Hospital Chiba Jpn
-
Meguro Kuniaki
東北大学 医学部分子診断学
-
Naoe T
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Odagiri Keiichi
Department Of Medicine Hamamatsu Red Cross Hospital
-
Matsuno Yoshihiro
Department Of Chemotherapy Tokyo Metropolitan Cancer And Infectious Diseases Center Komagome Hospita
-
Okada Masaya
Hyogo Coll. Medicine Nishinomiya Jpn
-
Jin-nai Itsuro
東京大学医科学研究所ヒトゲノム解析センター
-
IWATO Koji
Hiroshima Red Cross Hospital and Atomic-Bomb Survivors Hospital
-
Oshimi Kazuo
Division Of Hematology Department Of Medicine Juntendo University School Of Medicine
-
Uike Naokuni
Department Of Hemato-oncology Kyushu Cancer Center
-
Tanii Hiromi
Novartis Pharma K.k.
-
Tojo A
Univ. Tokyo Tokyo Jpn
-
Usuki Kensuke
Division Of Hematology Ntt Kanto Medical Center
-
Miyamura Koichi
Department Of Hematology And Rheumatology Tohoku University Graduate School Of Medicine
-
Miyamura K
Tohoku Univ. School Of Medicine Sendai Jpn
-
Miyamoto Ken-ichi
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
Oshimi Kazuo
Department Of Hematology Juntendo University Tokyo
-
Ohnishi Kazunori
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Kobayashi Yukio
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
Morishima Yasuo
Department Of Hematology And Cell Therapy Aichi Cancer Center Central Hospital
-
Okamoto Shin-ichiro
Division Of Hematology Department Of Medicine Keio University School Of Medicine
-
MITSUI Yoko
Department of Surgery
-
Jinnai Itsuro
Division Of Hematology Department Of Internal Medicine Saitama Medical School
-
Matsuo Yuji
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi
-
Miyamura Koichi
東北大学 医学系研究科血液･免疫病学分野
-
Morishima Yasuo
Department Of Hematology And Chemotherapy
-
Usui Noriko
Jikei Univ. Hospital Tokyo Jpn
-
Usui Noriko
The "lung Injury By Bortezomib" Joint Committee Of The Japanese Society Of Hematology And
-
Oshimi Kazuo
Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Kobayashi Masayuki
Hematology Division National Cancer Center Hospital
-
Murai Yoshiro
Department Of Hematology Tama Hokubu Medical Center
-
Taguchi Hirokuni
Department Of Internal Medicine Kochi Medical School
-
Tomita Akihiro
First Department Of Internal Medicine Nagoya University School Of Medicine
-
Okamoto Shin-ichiro
Department Of Medicine Keio University School Of Medicine
-
Miyazawa Keisuke
Department Of Hematology Tokyo Medical University
-
岡田 昌也
兵庫医科大学病院血液内科
-
URABE Akio
Division of Hematology, NTT Kanto Medical Center
-
Morishita Yoshihisa
Department Of Hematology And Oncology Ja Aichi Showa Hospital
-
Okamoto Shinichiro
Division Of Hematology Department Of Medicine Keio University School Of Medicine
-
Okamoto Shinichiro
Division Of Hematology/infectious Disease/rheumatology School Of Medicine Keio University
-
Kagami Yoshitoyo
Department Of Pathology School Of Medicine Kurume University
-
Matsumoto Yosuke
Department Of Molecular Hematology And Oncology Graduate School Of Medical Science Kyoto Prefectural
-
Moriuchi Yukiyoshi
Nagasaki Cml Study Group Nagasaki Jpn
-
Kawaguchi Tatsuya
Department Of Hematology And Infectious Diseases Kumamoto University Graduate School Of Medical Scie
-
Miyazaki Yoshitsugu
Second Department Of Internal Medicine Nagasaki University Graduate School Of Biomedical Science
-
Okamoto Shinichiro
Keio Univ. School Of Medicine Tokyo Jpn
-
Kyo T
Hiroshima Red Cross Hospital & Atomic‐bomb Survivors Hospital Hiroshima Jpn
-
Maeda Yasuhiro
Kinki Univ. School Of Medicine Osaka‐sayama Jpn
-
Okamoto Susumu
Department Of Internal Medicine Division Of Gastroenterology And Hepatology Keio University School O
-
Ohhashi Kyoichi
Department Of Clinical Pharmacology And Therapeutics Hamamatsu University School Of Medicine
-
Tojo Arinobu
The Institute Of Medical Science The University Of Tokyo
-
Kinoshita Tomohiro
Department Of Hematology Nagoya University School Of Medicine
-
Kawaguchi Tatsuya
Kumamoto Univ. Graduate School Of Medical Sci. Kumamoto Jpn
-
Takeyama K
National Cancer Center Hospital Tokyo Jpn
-
Usui Noriko
Division Of Oncology & Hematology Department Of Internal Medicine The Jikei University School Of
-
Komiyam Y
Akita Univ. School Of Medicine Akita Jpn
-
Kawai Yasukazu
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
Maki Kazuhiro
Department Of Hematology Dokkyo University School Of Medicine
-
Naruse T
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Urabe A
Ntt Kanto Medical Center
-
Miyazaki Yasushi
Department Of Hematology Kinki University School Of Medicine
-
Tojo Arinobu
Univ. Tokyo Tokyo Jpn
-
Yano Kunio
県西部浜松医療センター
-
Takeshita Akihiro
Hamamatsu Univ. School Of Medicine Shizuoka Jpn
-
Ohashi K
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Ohnishi Kazunori
Cancer Center Hamamatsu University School Of Medicine
-
Morishima Yasuo
Department Of Pathology And Oncology Institute Of Medical Science University Of Tokyo
-
Kimura Yoshizo
Department Of Pathology School Of Medicine Kurume University
-
Mori Shinichiro
Department Of Hematology And Oncology Kansai Medical University Hirakata Hospital
-
Tanaka Hideo
Hiroshima Univ. Hospital Hiroshima Jpn
-
Ohmachi Ken
Department Of Cell Pathology Graduate School Of Medical Sciences Kumamoto University
-
Nakano Tatsunori
Second Departmant Of Medicine Nagoya City University Medical School
-
Miyazaki Koji
Department Of Hematology Kitasato University Hospital
-
Ishikawa Jun
Osaka Medical Center For Cancer And Cardiovascular Diseases
-
Ohyashiki Kazuma
Tokyo Medical Univ. Tokyo Jpn
-
OKAMOTO Shin-ichiro
Keio University Hospital
関連論文
- ゲノム情報を生かした個別化医療 (特集 固形癌の最新治療--癌治療への新たな取り組み) -- (治療の新たな取り組み 個別化治療)
- Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
- P-674 大腸癌肝転移切除例のSurgical Marginについての遺伝子学的および組織学的検討
- PP-1137 大腸癌肝転移に対する外科的治療戦略 : Surgical Marginについての遺伝子学的および臨床病理学的検討
- Interlaboratory Comparison of Quantitative RT-PCR Based Detection for Minimal Residual Disease in Leukemias : A Standardization Approach in Japan
- SF-107-4 大腸sm癌のリンパ節転移と遺伝子群のマイクロアレイによる解析(第107回日本外科学会定期学術集会)
- 大腸の増殖形式(PG・NPG)と遺伝子群のマイクロアレイによる解析,悪性度についての検討
- マイクロアレイによる大腸癌の異時性肝転移の高リスク群の抽出
- Successful treatment of minimal residual disease-positive Philadelphia chromosome-positive acute lymphoblastic leukemia with imatinib followed by reduced-intensity unrelated cord blood transplantation after allogeneic peripheral blood stein cell transplan
- Prospective trial of high-dose chemotherapy followed by infusions of peripheral blood stem cells and dose-escalated donor lymphocytes for relapsed leukemia after allogeneic stem cell transplantation
- SY-1-2-5 肝細胞癌の進展機構解析による新規分子標的の同定(シンポジウム1-2 消化器癌の発生機序から見た治療戦略-肝胆膵癌,第62回日本消化器外科学会定期学術総会)
- PS-095-1 n0乳癌における再発予後予測システムの検討
- SY-6-6 癌遺伝子発現パターンを用いたPaclitaxelの治療効果予知 : 局所進行乳癌に対する術前化療による解析
- 早期大腸癌の発育形態と Ras-signaling Pathway 異常(第105回日本外科学会定期学術集会)
- PS-117-2 散発性大腸癌発癌におけるhMLH1発現低下の意義
- Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy
- Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma : morphological, immunohistochemical, and FISH analyses
- Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
- A-3 インベーダ法によるSNP遺伝子型データの2変量正規混合分布に基づく分類(企画セッション:SNPデータの解析における統計的諸問題)(2003年度統計関連学会連合大会記録(日本統計学会第71回大会))
- Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients
- 発がん・増殖 BRCA遺伝子機能とその機能欠損による乳癌発生機序 (乳癌--基礎と臨床の架け橋)
- 図説 最新のゲノムワイド解析技術 (特集 ゲノム研究最前線--疾患ゲノム研究の現状と展望)
- 癌と骨転移のゲノム学 (特集 骨・破壊と再生のゲノム医学)
- 遺伝性乳癌の分子遺伝学--BRCA1を中心に (癌抑制遺伝子--最新トピックス)
- SNPsと有害事象情報 (特集 分子・細胞標的治療--基礎と臨床) -- (基礎)
- がんの遺伝解析 (特集 ポストゲノム時代の医療) -- (ゲノム解析からの病態解明)
- 大腸癌表層部と先進部の発現プロファイル解析
- IS-3-4 乳がん術前化学療法の効果予測システム開発の試み(第108回日本外科会定期学術集会)
- A Japanese patient with Li-Fraumeni syndrome who had nine primary malignancies associated with a germline mutation of the p53 tumor-suppressor gene
- SF-108-2 大腸癌先進部脱分化に関与する遺伝子群の同定と機能ネットワークの構築(第107回日本外科学会定期学術集会)
- O-109 原発性肺癌切除時の開胸時胸腔内洗浄液における微量肺癌細胞の検出と細胞診の比較(肺癌と分子生物学2, 第47回日本肺癌学会総会)
- DP-009-4 包括的遺伝子発現解析による膵癌リンパ節転移予測マーカーの同定(第108回日本外科学会定期学術集会)
- Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
- Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
- Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer
- Management of infection in patients with acute leukemia during chemotherapy in Japan : questionnaire analysis by the Japan Adult Leukemia Study Group
- A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
- Dose Modification of Imatinib by Monitoring the Level of BCR-ABL Transcript in Chronic Myelogenous Leukemia
- Imatinib Mesylate in Conjunction with Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Philadelphia Chromosome Positive Leukemias : Report of 4 Cases
- Detection of Clone-Specific Immunoglobulin Heavy Chain Genes in the Bone Marrow of B-cell-Lineage Lymphoma after Treatment
- High Expression of YB-1 Gene in Erythroid Cells in Patients with Refractory Anemia
- P-7 原発性肺癌切除時の開胸時胸腔内洗浄液におけるCEA-mRNAの検出の意義(一般演題(ポスター) トランスレーショナルリサーチ,第48回日本肺癌学会総会)
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
- Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
- 乳がんのLarge-scale genomic study
- Monosomies 7p and 12p and FLT3 internal tandem duplication : possible markers for diagnosis of T/myeloid biphenotypic acute leukemia and its clonal evolution
- Allelic Losses of Loci at 3p25.1,8p22,13q12,17p13.3,and 22q13 Correlate with Postoperative Recurrence in Breast Cancer
- Successful cord blood transplantation for mycosis fungoides.
- Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma
- Primary Hepatic Follicular Lymphoma : A Case Report and Discussion of Chemotherapy and Favorable Outcomes
- HNPCC患者の放射線治療の安全性に関する検討(第105回日本外科学会定期学術集会)
- Histological Features of Breast Cancer, Highly Sensitive to Chemotherapy
- Identifying haplotype block structure using an ancestor-derived model
- A phase II, open-label, sequential-cohort, dose-escalation study of romiplostim in Japanese patients with chronic immune thrombocytopenic purpura
- Increased incidence of interstitial pneumonia by CHOP combined with rituximab
- Impaired TCR signaling through dysfunction of lipid rafts in sphingomyelin synthase 1 (SMS1)-knockdown T cells
- Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study
- Allelic Loss at 1p34,13q12,17p13.3,and 17q21.1 Correlates With Poor Postoperative Prognosis in Breast Cancer
- Correlation of Allelic Loss with Poor Postoperative Survival in Breast Cancer
- Frequent Allelic Loss at 6q26-27 in Breast Carcinomas of the Solid-tubular Histologic Type
- Correlation of Allelic Losses and Clinicopathological Factors in Primary Breast Cancers
- Mapping of a Breast Cancer Tumor Suppressor Gene Locus to a 4-cM Interval on Chromosome 18q21
- Clinicopathological Features of Hereditary Breast Cancer
- Expression profiling to predict postoperative prognosis for estrogen receptor-negative breast cancers by analysis of 25,344 genes on a cDNA microarray
- Fludarabine- and Cyclophosphamide-Based Nonmyelobalative Conditioning Regimen for Transplantation of Chronic Granulomatous Disease : Possible Correlation with Prolonged Pure Red Cell Aplasia
- Nucleotide Alteration of Retinoblastoma Protein-Interacting Zinc Finger Gene, RIZ, in Human Leukemia
- Tocilizumab is effective for pulmonary hypertension associated with multicentric Castleman's disease
- Identification of Rad51 alteration in patients with bilateral breast cancer
- High proportion of missense mutations of the BRCA1 and BRCA2 genes in Japanese breast cancer families
- Multiplex Mutation Screening of the BRCA1 Gene in 1000 Japanese Breast Cancers
- Infrequent Mutation of the H-Cadherin Gene on Chromosome 16q24 in Human Breast Cancers
- Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer
- Bilateral Nonpalpable Breast Carcinomas in a Patient with BRCA2 Germ Line Mutation and Past History of Osteosarcoma
- Clinical features of adult acute leukemia with 11q23 abnormalities in Japan : a co-operative multicenter study
- Long-term Follow-up of 14 Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia following Autologous Bone Marrow Transplantation in First Complete Remission
- A safety, pharmacokinetic and pharmacodynamic investigation of deferasirox (Exjade^【○!R】, ICL670) in patients with transfusion-dependent anemias and iron-overload : a Phase I study in Japan
- Successful Nonmyeloablative Bone Marrow Transplantation for Leukocyte Adhesion Deficiency Type I from an Unrelated Donor
- Significance of Decreased Plasma D-Dimer Levels following Lipopolysaccharide-Induced Disseminated Intravascular Coagulation in Rats
- Recombinant adeno-associated virus-mediated gene transfer into human leukemia cell lines
- Decreased risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with the 5,10-methylenetetrahydrofolate reductase 677TT genotype
- Serologically HLA-DR-Mismatched Unrelated Donors Might Provide a Valuable Alternative in Allogeneic Transplantation : Experience from a Single Japanese Institution
- Stable Engraftment after a Conditioning Regimen with Fludarabine and Melphalan for Bone Marrow Transplantation from an Unrelated Donor
- Severe Hypercholesterolemia Associated with Decreased Hepatic Triglyceride Lipase Activity and Pseudohyponatremia in Patients after Allogeneic Stem Cell Transplantation
- CD137-guided isolation and expansion of antigen-specific CD8 cells for potential use in adoptive immunotherapy
- Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia : A report from the BINGO study
- Clinical efficacy and safety of biapenem for febrile neutropenia in patients with underlying hematopoietic diseases : a multi-institutional study
- Mismatched human leukocyte antigen class II-restricted CD8^+ cytotoxic T cells may mediate selective graft-versus-leukemia effects following allogeneic hematopoietic cell transplantation
- Romiplostim for the treatment of chronic immune thrombocytopenia in adult Japanese patients : a double-blind, randomized Phase III clinical trial
- Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
- Diagnosis of Intestinal Graft-versus-Host Disease and Thrombotic Microangiopathy after Allogeneic Stem Cell Transplantation
- Dexamethasone palmitate successfully attenuates hemophagocytic syndrome after allogeneic stem cell transplantation : macrophage-targeted steroid therapy
- An open-label extension study evaluating the safety and efficacy of romiplostim for up to 3.5 years in thrombocytopenic Japanese patients with immune thrombocytopenic purpura (ITP)